Wasif M. Saif, MD, is professor of medicine, director of the Gastrointestinal Oncology Program, and program leader for Experimental Therapeutics, Department of Medicine, at Tufts University School of Medicine and Tufts Medical Center in Boston, Massachusetts. Dr Saif specializes in caring for patients with gastrointestinal malignancies; in particular, pancreatic and colorectal cancers. Over the last two decades, his research efforts have focused on the developing novel agents and treatment approaches for the treatment of cancer. As part of this effort, Dr Saif has worked as the principal investigator of multiple national and international studies investigating novel agents in the treatment of GI cancers. His research interest focuses on cancer pharmacology, pharmacogenetics, cancer drug development, and clinical investigations.
Dr Saif graduated from King Edward Medical University, Lahore, Pakistan. He completed his internal medicine residency at the University of Connecticut School of Medicine in Farmington, and a medical oncology fellowship at the National Cancer Institute, NIH, in Bethesda, Maryland, and the National Naval Medical Center, Bethesda. Dr Saif also completed a hematology fellowship at the National Heart, Lung, and Blood Institute (NHLBI), NIH, in Bethesda. After the clinical fellowship, he became a junior investigator in the Investigational Drug Branch, NCI, where he worked in the Gastrointestinal Malignancies Section.
Dr Saif is a member of the American Society of Clinical Oncology, American Society for Pharmacology and Experimental Therapeutics, and many others. He has published over 450 peer-reviewed articles about cancer treatment and research, over 80 abstracts and 20 book chapters, and serves on the editorial board of over 20 peer-reviewed cancer journals.
Personalizing Treatment: A Strategy to Improve Outcomes for Patients with mCRC